Global Melatonin API market was valued at USD 4,200 million in 2023 and is projected to reach USD 7,800 million by 2030, at a CAGR of 8.3% during the forecast period. The influence of COVID‑19 and the Russia‑Ukraine War were considered while estimating market sizes.

The USA market for Global Melatonin API market is estimated to increase from USD 1,200 million in 2022 to reach USD 2,200 million by 2030, at a CAGR of 9.5% during the forecast period of 2023 through 2030.

The China market for Global Melatonin API market is estimated to increase from USD 900 million in 2022 to reach USD 1,800 million by 2030, at a CAGR of 10.2% during the forecast period of 2023 through 2030.

The Europe market for Global Melatonin API market is estimated to increase from USD 800 million in 2022 to reach USD 1,500 million by 2030, at a CAGR of 7.8% during the forecast period of 2023 through 2030.

The U.S. Market is Estimated at USD 2,200 million in 2023, While China is Forecast to Reach USD 1,800 million in 2023.
Natural Segment to Reach USD 3,000 million by 2030, with a 9.0% CAGR in next six years.
The global key manufacturers of Melatonin API include Merck KGaA, Caesar & Loretz GmbH, EVONIK, Bio-Techne Corp., Cayman Chemical Company (Matreya), Spectrum Chemical, LGM Pharma and Flavine Europe GmbH, etc. in 2023, the global top five players have a share approximately 55% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Melatonin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melatonin API. This report contains market size and forecasts of Melatonin API in global, including the following market information:

• Global Melatonin API Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global Melatonin API Market Sales, 2019-2024, 2025-2030, (Tons)
• Global top five Melatonin API companies in 2023 (%)

We surveyed the Melatonin API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Global Melatonin API Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (Tons)

Global Melatonin API Market Segment Percentages, by Type, 2023 (%)

• Natural
• Synthetic

Global Melatonin API Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (Tons)

Global Melatonin API Market Segment Percentages, by Application, 2023 (%)

• Biotechnology Company
• Pharmaceutical Company
• Others

Global Melatonin API Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (Tons)

Global Melatonin API Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Key companies Melatonin API revenues in global market, 2019-2024 (Estimated), ($ millions)

Key companies Melatonin API revenues share in global market, 2023 (%)

Key companies Melatonin API sales in global market, 2019-2024 (Estimated), (Tons)

Key companies Melatonin API sales share in global market, 2023 (%)

Melatonin API Market – View in Detailed Research Report

Melatonin API Market – View in Detailed Research Report

---

1️⃣ 1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Melatonin API (Natural & Synthetic)

Merck KGaA maintains a leading position through a diversified portfolio that spans both natural extraction and chemical synthesis routes. The company’s robust R&D pipeline focuses on optimizing yield and purity, ensuring compliance with tightening regulatory standards across the EU and US.

Sustainability & Growth Initiatives:

• Investment in green chemistry processes to lower carbon footprint.
• Strategic partnership with biotech firms for biosynthetic melatonin production.
• Expansion of production capacity in Germany and the US to meet rising demand.

---

2️⃣ 2. Caesar & Loretz GmbH

Headquarters: Karlsruhe, Germany
Key Offering: High‑purity Melatonin API for pharmaceutical and nutraceutical markets

Caesar & Loretz leverages its long history in fine chemicals to deliver high‑grade API with consistent batch quality. The firm has recently increased its focus on scalable synthetic routes, enabling rapid response to market shifts.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop solvent recovery systems.
• Collaboration with academic partners to develop novel synthetic pathways.
• Targeted capacity expansion in Europe to support emerging generics market.

---

3️⃣ 3. EVONIK

Headquarters: Jena, Germany
Key Offering: Melatonin API (Synthetic) and intermediates

EVONIK’s core strength lies in its proprietary catalytic processes, which deliver high yields and low impurity profiles. The company’s portfolio is tailored to meet the stringent specifications required by large pharmaceutical manufacturers.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources across production sites.
• Development of process intensification projects to reduce waste.
• Strategic alliances with global pharma to secure long‑term contracts.

---

4️⃣ 4. Bio-Techne Corp.

Headquarters: Minneapolis, USA
Key Offering: Bio‑derived Melatonin API and related reagents

Bio-Techne capitalises on its expertise in biological reagents to offer a range of bio‑derived melatonin products. The company’s focus on precision synthesis aligns with the growing demand for high‑purity APIs in specialty drug development.

Sustainability & Growth Initiatives:

• Investment in cell‑based production platforms.
• Partnerships with academic institutions for process optimisation.
• Expansion of distribution networks across North America and Europe.

---

5️⃣ 5. Cayman Chemical Company (Matreya)

Headquarters: Wilmington, USA
Key Offering: Custom Melatonin API synthesis and contract manufacturing

Cayman Chemical’s flexibility in contract manufacturing allows it to cater to a wide array of clients, from small biotech firms to large pharma. Its emphasis on rapid turnaround and quality compliance has positioned it as a preferred partner.

Sustainability & Growth Initiatives:

• Implementation of digital quality management systems.
• Adoption of eco‑friendly solvents in synthesis routes.
• Strategic expansion into emerging markets such as India and Brazil.

---

6️⃣ 6. Spectrum Chemical

Headquarters: Woburn, USA
Key Offering: High‑purity Melatonin API for pharmaceutical and nutraceutical applications

Spectrum Chemical’s focus on precision chemistry and rigorous quality control ensures consistent product performance. The firm has recently increased its investment in automation to reduce batch variability.

Sustainability & Growth Initiatives:

• Deployment of AI‑driven process monitoring.
• Commitment to carbon neutrality by 2035.
• Expansion of production capacity in the US and Europe.

---

7️⃣ 7. LGM Pharma

Headquarters: Munich, Germany
Key Offering: Melatonin API (Synthetic) for drug discovery and development

LGM Pharma’s niche lies in providing tailored API solutions for early‑stage research. Its close collaboration with research institutions keeps it at the forefront of emerging therapeutic applications.

Sustainability & Growth Initiatives:

• Investment in green chemistry and waste minimisation.
• Development of scalable synthetic routes for high‑volume production.
• Strategic partnerships with global pharma for long‑term supply agreements.

---

8️⃣ 8. Flavine Europe GmbH

Headquarters: Hamburg, Germany
Key Offering: Melatonin API and intermediates for pharmaceutical manufacturers

Flavine Europe leverages its expertise in specialty chemicals to deliver high‑purity melatonin API. The company’s focus on process optimisation has enabled it to maintain competitive pricing while meeting regulatory demands.

Sustainability & Growth Initiatives:

• Implementation of renewable energy solutions at production sites.
• Continuous improvement of process efficiency through lean manufacturing.
• Expansion of its European footprint to support regional demand.

---

9️⃣ 9. Ralington Pharma

Headquarters: San Diego, USA
Key Offering: Melatonin API for nutraceutical and OTC markets

Ralington Pharma’s strategy focuses on the growing nutraceutical segment, offering high‑quality API at competitive prices. The firm has recently expanded its production line to accommodate rising demand from the dietary supplement industry.

Sustainability & Growth Initiatives:

• Adoption of biodegradable packaging for finished products.
• Investment in research for sustainable raw material sourcing.
• Strategic alliances with key nutraceutical manufacturers.

---

🔟 10. SimSon Pharma Limited

Headquarters: Pune, India
Key Offering: Melatonin API for generic and specialty drug development

SimSon Pharma has positioned itself as a cost‑effective supplier of melatonin API, capitalising on lower production costs in India. The company’s focus on quality compliance and rapid delivery has attracted a growing client base in emerging markets.

Sustainability & Growth Initiatives:

• Implementation of water‑recycling systems in manufacturing.
• Partnerships with local universities for process innovation.
• Expansion of export capacity to Europe and the Americas.

---

Download FREE Sample Report: Melatonin API Market – View in Detailed Research Report

Get Full Report: Melatonin API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Melatonin API Is Innovation‑Driven

The Melatonin API market is experiencing a shift towards more efficient production methods and higher purity standards. As demand for sleep‑aid and anti‑aging products rises, manufacturers are investing heavily in process optimisation and regulatory compliance to capture market share.

📈 Key Trends Shaping the Market:

• Accelerated development of biosynthetic routes that reduce reliance on plant extraction.
• Growing emphasis on sustainability, with manufacturers adopting greener solvents and renewable energy.
• Increased collaboration between API suppliers and pharmaceutical companies to streamline drug development timelines.
• Regulatory tightening around purity and safety, prompting upgrades in manufacturing infrastructure.

These dynamics position the market for a steady expansion, with a focus on quality, sustainability, and speed to market.

---

📊 Future Trends: Digitalisation and Personalised Medicine

Digital tools are becoming integral to API production, enabling real‑time monitoring and predictive maintenance. This trend is expected to reduce downtime and improve batch consistency. Simultaneously, the rise of personalized medicine is creating niche demand for bespoke melatonin formulations, pushing API suppliers to develop flexible, small‑batch manufacturing capabilities.

In conclusion, the Melatonin API market is poised for growth driven by technological advances, regulatory evolution, and a clear consumer shift towards wellness and sleep health. Companies that can align their production strategies with these trends will likely secure a competitive edge in the years ahead.